Financial reports
10-K/A
2023 FY
Annual report (amended)
10 Apr 24
10-K
2023 FY
Annual report
6 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
25 Apr 23
10-K
2022 FY
Annual report
8 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
TScan Therapeutics Announces Launch of $125 million Proposed
17 Apr 24
8-K
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
16 Apr 24
8-K
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert
8 Apr 24
8-K
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
6 Mar 24
8-K
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
29 Jan 24
8-K
Regulation FD Disclosure
11 Dec 23
8-K
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
7 Dec 23
8-K
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9 Nov 23
8-K
TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
10 Aug 23
8-K
Departure of Directors or Certain Officers
24 Jul 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
17 Apr 24
FWP
Free writing prospectus
17 Apr 24
424B5
Prospectus supplement for primary offering
16 Apr 24
S-3
Shelf registration
6 Mar 24
S-8
Registration of securities for employees
6 Mar 24
S-8
Registration of securities for employees
16 Jun 23
424B5
Prospectus supplement for primary offering
26 May 23
FWP
Free writing prospectus
26 May 23
424B5
Prospectus supplement for primary offering
25 May 23
424B5
Prospectus supplement for primary offering
16 May 23
Other
EFFECT
Notice of effectiveness
15 Apr 24
EFFECT
Notice of effectiveness
17 May 23
EFFECT
Notice of effectiveness
17 May 23
CORRESP
Correspondence with SEC
15 May 23
CORRESP
Correspondence with SEC
15 May 23
CORRESP
Correspondence with SEC
10 May 23
CORRESP
Correspondence with SEC
10 May 23
UPLOAD
Letter from SEC
15 Nov 22
UPLOAD
Letter from SEC
15 Nov 22
EFFECT
Notice of effectiveness
16 Jul 21
Ownership
SC 13D/A
BAKER BROS. ADVISORS LP
23 Apr 24
4
JULIAN BAKER
23 Apr 24
4
Weston Nichols
23 Apr 24
SC 13G/A
K2 HealthVentures Equity Trust LLC
14 Feb 24
SC 13G/A
GV 2017, L.P.
9 Feb 24
SC 13G/A
Pitango HealthTech Fund I, L.P.
8 Feb 24
SC 13G/A
ADAGE CAPITAL PARTNERS GP, L.L.C.
7 Feb 24
4
Jason Amello
2 Feb 24
3
Jason Amello
2 Feb 24
4
TIMOTHY J BARBERICH
21 Dec 23